2022 Expert consensus on the use of laser ablation for papillary thyroid microcarcinoma

References

• Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021;9(4):193–194.
   PubMed Web of Science ®Google Scholar
• Shafique K, LiVolsi VA, Montone K, et al. Papillary thyroid microcarcinoma: reclassification to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a retrospective clinicopathologic study. Endocr Pathol. 2018;29(4):339–345.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Maeda T, Izumi K, et al. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65(5):1173–1179.
   PubMed Web of Science ®Google Scholar
• Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90(1):72–76.
   PubMed Web of Science ®Google Scholar
• Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56(3):531–538.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.
   PubMed Web of Science ®Google Scholar
• Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13(4):381–387.
   PubMed Web of Science ®Google Scholar
• Tufano RP, Pace-Asciak P, Russell JO, et al. Update of radiofrequency ablation for treating benign and malignant thyroid nodules. The future is now. Front Endocrinol (Lausanne). 2021;12:698689.
   PubMed Web of Science ®Google Scholar
• Papini E, Monpeyssen H, Frasoldati A, et al. 2020 European thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J. 2020;9(4):172–185.
   PubMed Web of Science ®Google Scholar
• Mauri G, Hegedus L, Bandula S, et al. European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197.
   PubMed Web of Science ®Google Scholar
• Xu D, Ge M, Yang A, et al. Expert consensus workshop report: guidelines for thermal ablation of thyroid tumors (2019 edition). J Cancer Res Ther. 2020;16(5):960–966.
   PubMed Web of Science ®Google Scholar
• Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21(8):917–920.
   PubMed Web of Science ®Google Scholar
• Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23(12):1578–1582.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Chung SM, Kim H, et al. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid. 2021;31(11):1723–1729.
   PubMed Web of Science ®Google Scholar
• Gambelunghe G, Stefanetti E, Avenia N, et al. Percutaneous ultrasound-guided laser ablation of benign thyroid nodules: results of 10-year follow-up in 171 patients. J Endocr Soc. 2021;5(7):bvab081.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.
   PubMed Web of Science ®Google Scholar
• Peng K, Zhou P, Liu W. Long-term efficacy of ultrasound-guided percutaneous laser ablation for low-risk papillary thyroid microcarcinoma: a 5-year follow-up study. Biomed Res Int. 2021;2021:6616826.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719–725.
   PubMed Web of Science ®Google Scholar
• Ridouani F, Tuttle RM, Ghosn M, et al. Ultrasound-guided percutaneous laser ablation of the thyroid gland in a swine model: comparison of ablation parameters and ablation zone dimensions. Cardiovasc Intervent Radiol. 2021;44(11):1798–1806.
   PubMed Web of Science ®Google Scholar
• Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100(10):3903–3910.
   PubMed Web of Science ®Google Scholar
• Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst. 2003;95(8):625–627.
   PubMed Web of Science ®Google Scholar
• Melo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2014;99(5):E754–E765.
   PubMed Web of Science ®Google Scholar
• Xing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32(25):2718–2726.
   PubMed Web of Science ®Google Scholar
• Lee SY, Savides TJ. Management of anticoagulation before and after gastrointestinal endoscopy. Am J Gastroenterol. 2010;105(3):703.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
   PubMed Web of Science ®Google Scholar
• Valcavi R, Riganti F, Bertani A, et al. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010;20(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Di Rienzo G, Surrente C, Lopez C, et al. Tracheal laceration after laser ablation of nodular goitre. Interact Cardiovasc Thorac Surg. 2012;14(1):115–116.
   PubMed Web of Science ®Google Scholar
• Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: preliminary results. Eur Radiol. 2017;27(7):2934–2940.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. The role of core needle biopsy for the evaluation of thyroid nodules with suspicious ultrasound features. Korean J Radiol. 2019;20(1):158–165.
   PubMed Web of Science ®Google Scholar
• Chung SR, Suh CH, Baek JH, et al. The role of core needle biopsy in the diagnosis of initially detected thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2018;28(11):4909–4918.
   PubMed Web of Science ®Google Scholar
• Na DG, Baek JH, Jung SL, et al. Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology. Korean J Radiol. 2017;18(1):217–237.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. 2019;112:14–21.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Baek SM, Na DG, et al. Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis. Eur Radiol. 2021;31(9):6446–6456.
   PubMed Web of Science ®Google Scholar
• Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694.
   PubMed Web of Science ®Google Scholar
• Li J, Liu Y, Liu J, et al. A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery. Int J Hyperthermia. 2019;36(1):640–646.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012;97(4):1250–1257.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Cho YJ, Kim SJ, et al. Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg. 2011;35(2):318–323.
   PubMed Web of Science ®Google Scholar
• Wang LY, Smith AW, Palmer FL, et al. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. Thyroid. 2015;25(3):300–307.
   PubMed Web of Science ®Google Scholar
• Pajamäki N, Metso S, Hakala T, et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2018;88(2):303–310.
   PubMed Web of Science ®Google Scholar
• Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249–1252.
   PubMed Web of Science ®Google Scholar